Note: Ingredients listed on restricted chemical lists
EC/CAS
2530-83-8
Name of the chemical
[3-(2,3-epoxypropoxy)propyl]trimethoxy silane
Concentration
0-<10
EC/CAS
26471-62-5
Name of the chemical
m-Tolylidendiisocyanat
Concentration
<1%
General Information
Version
2.02
Revision date
2022-11-13
Product name
SEAL N FLEX 1 WHITE
supplier name
Bostik Australia Pty Ltd
Manufacturer Name
Bostik Australia Pty Ltd
Icons in SDS
Company Information
company name
Bostik Australia Pty Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
au-bostik-sds@bostik.com
GHS Information
Signal word
WARNING
Hazard Codes
Hazard statements (CLP)
H319, H332
Hazard statements
Code
Statements
H319
Causes serious eye irritation
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Acute toxicity - Inhalation (Vapors) Category 4 - (H332) Serious eye damage/eye irritation Category 2 - (H319)
2.2 Label elements
Exclamation mark
Signal word
WARNING
Hazard statements
H319 - Causes serious eye irritation H332 - Harmful if inhaled Reacts violently with water
Prevention
Avoid breathing dust/fume/gas/mist/vapors/spray Use only outdoors or in a well-ventilated area Wash face, hands and any exposed skin thoroughly after handling Wear eye/face protection
Response
IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing If eye irritation persists: Get medical advice/attention IF INHALED: Remove person to fresh air and keep comfortable for breathing Call a doctor if you feel unwell
Other hazards which do not result in classification
Causes mild skin irritation. Standard for Uniform Scheduling of Medicines and Poisons (SUSMP) Classified as a scheduled poison according to the Standard for Uniform Scheduling of Medicines and Poisons (SUSMP) Poison Schedule Number 6 Label requirements in accordance with SUSMP POISON KEEP OUT OF REACH OF CHILDREN READ SAFETY DIRECTIONS BEFORE OPENING OR USING Section 3: Composition and information on ingredients, in accordance with Schedule 8